CHAPEL HILL -- A scientific collaboration based at the University of North Carolina at Chapel Hill has broken new ground for future drug design and development for brain disorders such as Parkinson’s ...
Structure-Based Drug Design (SBDD) has evolved a graphic (Small)great deal over the past 30 years since the concept of the “Lock and Key” hypothesis was first reduced to practice in the HIV-1 protease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback